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SURGERY FOR CONGENITAL 
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PLASMA ANTIOXIDANT 
DEPLETION AFTER 
CARDIOPULMONARY 
BYPASS IN OPERATIONS 
FOR CONGENITAL HEART 
DISEASE 
We describe the use of two in vitro tests to characterize plasma antioxidant 
capacity at the time of cardiac bypass in operations for congenital heart 
disease in 30 patients aged 3 days to 16 years (average 4.4 - 0.9 years 
[standard error]). Bypass and crossclamp time, circuit volume, and type of 
operation were recorded for each patient. First, a test of plasma radical 
antioxidant power measured chain breaking (secondary) antioxidant capacity 
of plasma to prevent oxidation of linoleic acid in vitro. Second, overall ability 
of plasma to prevent lipid peroxidation was assessed by a classic test of plasma 
inhibition of malondialdehyde formation in a beef brain homogenate. Plasma 
total radical antioxidant power level at baseline was 0.74 - 0.03 /xmol/ml 
plasma, which decreased to 0.15 - 0.05 /xmo!/ml plasma after bypass (p < 
0.001) and 0.26 -+ 0.08 /xmol/ml plasma with recovery (n = 18, p < 0.001). 
Analysis of variance of postbypass total radical antioxidant power value 
showed age (p = 0.0002, r = 0.63) and bypass time (p = 0.009, r = 0.4677) to 
be significant factors. Pump prime volume in milliliters per kilogram and 
preoperative hemoglobin value were not significant factors. Beef brain malon- 
dialdehyde formation in vitro was limited 92% - 3% by normal plasma before 
operation versus 53% - 5% after operation (p < 0.001) and 51% - 5% at 
recovery after arrival in the pediatric intensive'care unit (p < 0.001). Analysis 
of variance of the changes from before to after operation showed age (p = 
0.0015, r = 0.55) and bypass time (p = 0.033, r = 0.39) to be significant factors. 
Thus antioxidant capacity of plasma is significantly diminished after cardio- 
pulmonary bypass in children. Young patient age and long duration of 
cardiopulmonary b pass are identified as factors that correlate positively with 
depletion of antioxidant capacity with bypass. (J THORAC CARDIOVASC SURG 
1995;110:165-71) 
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I nfants are clinically known to tolerate cardiopul- monary bypass less well than adults. Studies by 
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have provided important data in  this regard. Be- 
cause these latter investigators noted preservation 
of myocardial adenosine triphosphate during bypass 
to be a crucial factor, we have investigated cardio- 
pulmonary bypass from the perspective of  identify- 
ing factors that could come into play if a reperfusion 
injury were a significant effect. 
A number of investigators, beginning with Hearse 
and associates, 3 have suggested that reactive oxy- 
gen-containing species or "oxygen radicals" play a 
significant pathophysiologic role in reperfusion in- 
jury. Previous studies have shown evidence of con- 
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jugated diene and lipid peroxide production with 
bypass, but the clinical significance of these obser- 
vations is not known. 4-6 A cascade of complement 
activation, neutrophil activation, and interleukin 
production has been documented. 7' s Hydrogen per- 
oxide elevation and vitamin E depletion have been 
noted after bypass. 9' 10 During repair of tetralogy of 
Fallot, derangements of plasma antioxidant enzymes 
and elevated myocardial conjugated ienes have been 
demonstrated.11,12 These studies of tetralogy repair 
have suggested that an oxygen radical-mediated pro- 
cess could occur during bypaSs that is independent of 
myocardial ischemia nd reperfusion. 
Plasma antioxidants were investigated in this 
study with two tests that assess evidence of efforts to 
combat oxygen radical damage during bypass. The 
plasma total radical antioxidant test (TRAP assay) is 
a relatively new method but a modified version has 
now been used to investigate xtracorporeal circu- 
lation in adults. 13' 14 TRAP capacity was found to be 
increased in the adults after cardiopulmonary by- 
pass, with use of a modification of the initially 
published method. 14 The beef brain malondialde- 
hyde inhibition test (MDA inhibition) has not been 
previously used to investigate bypass. The TRAP 
and MDA inhibition tests complement each other 
because the TRAP assay measures econdary (or 
chain breaking) antioxidant capacity and the MDA 
inhibition test measures overall antioxidant capacity 
including primary enzymatic detoxification o f  reac- 
tive oxygen species in plasma. Rather than investi- 
gate  change in an isolated substance of unknown 
significance to the clinical setting of cardiac bypass 
such as vitamin E, urea, or bilirubin, we have studied 
two tests of global antioxidant capacity, a5 These 
studies should provide new information regarding 
the importance of oxygen radicals in cardiopulm 0- 
nary bypass and the extent of overall antioxidant 
depletion. 
Methods 
Samples. Antioxidant levels were measured in 30 in- 
fants and children, aged 3 days tO 16 years. Mean values 
(plus or minus the standard error) were as follows: age 
4.4 _+ 0.9 years,'weight 17.5 _+ 3.6 kg, body surface area 
0.64 _+ 0.08 m 2, hemoglobin 12.7 + 0.4 gm/dl, cardiopul- 
monary bypass time 106 _+ 8 minutes, and aortic cross, 
clamp time 54 _+ 5 minutes. Operations performed in- 
cluded atrial septal defect repair (9), ventricular septal 
defect repair, (6), aortic commissurotomy (2), subaortic 
membrane resection (2), Rastelli conduit revision (2), 
arterial switch operation for transposition of the great 
arteries (3), and one each of Senning procedure for 
transposition of the great arteries, ventricular septal de- 
fect repair with subaortic resection, Fontan procedure, 
bidirectional Glenn shunt, tetralogy repair, and mitral 
valve replacement. 
The only additive to the bypass circuit was mannitol 0.5 
gm/kg, which was added before institution of cardiopul- 
monary bypass. Plasma samples were obtained before and 
immediately after cardiopulmonary b pass and on patient 
arrival in the intensive care unit. No subjects were taken to 
a recovery room. Blood was drawn into clean plastic 
syringes and immediately transferred to tubes containing 
sodium heparin (3 ml) (Becton Dickinson, Inc., Oxnafd, 
Calif.) and placed on ice. The tubes were then centrifuged 
at 3500 rpm (1000g 1) at 4 ~ C and the supernatant plasma 
fraction separated. The plasma fraction was stored for up 
to 4 weeks at -70~ pending analysis. The amount of 
blood required was 3 to 5 ml to provide 1.2 to 1.5 ml of 
plasma for the two tests. The thiobarbituric acid reactive 
substances (TBARS) assay requires 0.3 ml of plasma for 
determination and was done in duplicate. The plasma 
antioxidant assay requires 100 txl of plasma nd was done 
in duplicate for this study. Informed consent was obtained 
from parents of patients included in the study using a 
protocol approved by the Institutional Review Board of 
West Virginia University. 
TRAP assay. The antioxidant est was done as de- 
scribed by Lindeman and associates 16 after Wayner and 
associates, 13 Oxidation of linoleic acid was initiated 
and then quenched, first with the unknown plasma sam- 
ple and then with a known amount of a control antioxi- 
dant, the water-soluble vitamin E analog, TROLOX 
(6-hydroxy-9,5,7,8-tetramethylchroman-2-carboxylic cid; 
Hoffmann-La Roche Inc., Nutley, N.J.). A ratio of the 
antioxidant capability of plasma to that of the TROLOX 
control was determined. Oxygen consumption was mea- 
sured in a YSI model 5300/5301/5331 oxygen electrode 
and bath system (Yellow Springs Instrument Corp., Yel- 
low Springs, Ohio) to quantify the reaction. For this 
determination 100 ~1 of plasma and 4 txl linoleic acid 
(Sigma Chemical Co., St. Louis, Mo.) were vortex-mixed 
together. Fifty microliters of this mixture was added to 3.0 
ml of phosphate-buffered saline solution (PBS; Sigma) 
containing 4.0 mmol/L 2,2'-azo-bis-(2-amidinopropane 
hydrochloride) (ABAP; Polysciences, Warrington, Pa.), 
the oxygen radical generator, at 37~ in the oxygen 
electrode cell. After the induction period in which the 
antioxidant activity of the plasma was consumed, 25 txl of 
0.4 mmol/L TROLOX was added to the cell. The antio• 
idant capacity of the plasma was calculated as follows: 
Antioxidant capacity = N(TROLOX) (Tplasma/TTRoLOX) 
(f), where N -- 2 (stoichiometric factor for TROLOX) and 
f = dilution factor (Fig. 1). 
Beef brain MDA inhibition assay. The method of 
St0ck~ and associates 17 was used for an indirect determi- 
nation of plasma ntioxidant capacity to correlate with the 
TRAP assay. This assay was used with correction for heine 
and bile pigment spectral interfering substances. 15 The 
beef brain MDA inhibition assay assesses antioxidant 
capacity of plasma by measuring the ability of the fluid tO 
prevent peroxidation of an ox or beef brain homogenate. 
This brain homogenate has been noted to undergo spon- 
taneous oxidation to form TBARS (mainly MDA) when 
left at room temperature. 
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Fig. 1. Peroxidation of linoleic acid is measured as decrease in dissolved oxygen from 100% to 0% in an 
oxygen electrode cell. TRAP is calculated by comparing reaction inhibition time(T) for plasma versus 
known amount of vitamin E analog, TROLOX (6-hydroxy-2,5,7,8- tetramethylchroman-2-carboxylic acid). 
ABAP is added to reaction cell to induce oxygen radical formation and lipid peroxidation of linoleic acid. 
Fresh brain was obtained from slaughterhouse cows. 
The tissue was sliced into small pieces. Ice-cold phos- 
phate-saline buffer (10 mmol/L KI-I2PO4/K2HPO4, pH 
7.4, in 0.142 mol/L NaC1; Sigma) was added in an amount 
to equal four times the brain weight. The brain was 
homogenized for 3 minutes and then spun at 1000 g-1 
(3500 rpm) for 15 minutes. Supernatant fluid was de- 
canted into 20 ml disposable containers and stored at 
-20 ~ C for up to 8 weeks. To perform assays, the brain 
stock was diluted with three additional volumes of PBS. 
Assays were done in duplicat e. Samples were prepared by 
adding 40/xl of plasma to 4 ml of dilute brain homoge- 
nate, and blanks were prepared by adding 40/xl of PBS to 
the dilute brain homogenate. Glass tubes were used. 
Homogenate was always added to plasma tO wash the 
small amount of plasma down the tube and facilitate 
mixing. A standard curve was constructed as part of each 
assay by measuring the MDA chromagen formed from 
1,1,4,4-tetramethoxy propane (Sigma) in 4 ml PBS. Tubes 
were incubated at 37 ~ C for 1 hour or held at 0 ~ C to allow 
minimal oxidation for time zero controls. Two milliliters 
of 25% trichloroacetic acid (Fisher Scientific Company, 
Pittsburgh, Pa.) were added to all tubes, which were then 
spun at 1000 g-~ (3500 rpm) for 15 minutes. Four 
milliliters of supernatant were removed and transferred to 
a new tube. One milliliter of 1% 2-thiobarbituric acid 
(Sigma, 10 gm/L wt/vol) was added to all tubes. Each tube 
was covered with a glass bead to exclude additional air 
during heating. All tubes were incubated at 95 ~ C for 15 
minutes. After incubation, test tubes were cooled in an ice 
water slurry. TBARS were extracted to an n-butanol- 
pyridine mixture (Fisher). Spectrophotometric absor- 
bances at 510, 532, and 560 nm were simultaneously 
determined. One-milliliter aliquots of the extract were 
aspirated into the flow cell by a sipper apparatus on a 
Beckman model DR-6 spectrophotometer (Beckma n In- 
struments, Inc. Fullerton, Calif.). Antioxidant activity 
(AOA) was calculated by the following formula (MDA = 
TBARS level from the beef brain homogenate): 
MDA (test) - MDA (time 0) 
AOA = 
MDA (PBS control) - MDA (time 0) 
Statistical analysis. Data analysis was done with paired 
and unpaired t tests as appropriate using Microsoft Excel 
spreadsheets. Single variable and multivariate analysis of 
variance was done 'with the Jmp statistical program for 
Macintosh and a Macintosh Ilci computer (Apple Com- 
puter, Cupertino, Calif.) after data were imported from 
Microsoft Excel (Microsoft Corporation, Redmond, 
Wash.). p Values of 0.05 or less were considered to be 
significant with actual values listed, unless p < 0.001. 
Results are expressed as mean plus orminus the standard 
error. 
Results 
Thirty subjects underwent eardiopulmonary by- 
pass for cardiac operation. Plasma from all subjects 
was evaluated with the TRAP assay and the beef 
brain MDA antioxidant activity assay. Before by- 
pass, the mean TRAP value for all 30 patients was 
0.74 _+ 0.03/_~mol antioxidant activity per milliliter of  
plasma. Baseline TRAP value varied directly with 
age of the child (r = 0.50, p = 0.0045). TRAP 
capacity decreased to 0.15 ___ 0.05/xmol per milliliter 
plasma after bypass (p < 0.001) and 0.26 - 0.08 
/xmol per milliliter plasma with recovery (n = 18, 
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Fig. 2. Plasma antioxidant capacity is shown at baseline (shaded columns), after bypass (black columns), 
and at recovery (hatched columns) for three age groups: less than i month, 1 to 12 months, and older than 
12 months. Column graph shows increased baseline levels in older age groups. Asterisks show significantp 
values versus baseline as follows: younger than 1 month: postbypass, p = 0.003 and recovery, p = 0.03; 1 
to 12 months: postbypass, p < 0.001; older than1 year: p0stbypass, p < 0.001 and recovery, p < 0.001. The 
amount of changes was not significantly different for three groups. 
p < 0.00i). Univariate analysis of variance showed 
age (r = 0.63,p = 0.0002) and bypass time (r = 0.47, 
p = 0.009) to be significantly correlated with TRAP 
values after bypass. Fig. 2 shows the 30 patients 
grouped by ages 0 to 1 month, 1 to 12 months, and 
1 to 16 years. Multivariate analysis of variance of 
postbypass TRAP value for the 20 patients older 
than 1 year of age showed age (p = 0.007) and 
bypass time (p = 0.05) to be significant factors in a 
model with a correlation coefficient (r) of 0.73 
(TRAP2 = 0.213 + 0.0374 years - 0.0025 cardio- 
pulmonary bypass time; p = 0.004 for the model). 
Hemoglobin value and presence or absence of cya- 
nosis were not predictive factors for the entire group 
or any of the subgroups of ages 0 to 1 month, 1 to 12 
months,, or older than 1 year. 
MDA inhibition before bypass was 92% _ 3% 
and dropped to 53% -+ 5% after bypass (p < 0.001). 
With recovery the value was 51% ___ 5% (p < 0.001, 
n = 20). Univariate analysis of variance showed age 
(r = 0.55, p = 0.0015) to be significantly correlated 
with differences in MDA inhibition values after 
bypass. Fig. 3 shows prebypass, postbypass, and 
recovery MDA inhibition values grouped by the 
same three age brackets. There is a trend toward 
higher postbypass levels with increased age. Bypass 
time was a significant factor but showed poor cor- 
relation with MDA inhibition values (r = 0.39, p = 
0.0329). Multivariate analysis of variance of differ- 
ences in MDA inhibition values showed age (p = 
0.0123) but not bypass time (p = 0.34) to be a 
significant factor in a model with a correlation 
coefficient (r) of 0.575 (p = 0.0044 for the model). 
Analysis of variance showed a significant correlation 
between actual TRAP values and the MDA inhibi- 
tion values (TRAP = 0.38 - 0.0062 beef MDA; r = 
0,506, p = 0.0043 for MDA inhibition and p = 
0.0002 for the y intercept). 
In addition to the notation that 21 patients 
showed complete depletion of the TRAP capacity 
after bypass, the striking observation of the study 
was that postbypass and recovery plasma samples 
from these children produced rapid spontaneous 
oxidation of the linoleic acid in the oxygen consump- 
tion cell. This occurred before addition of the 
oxygen radical generator ABAP (Fig. 4). The rela- 
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Fig. 3. MDA beef brain values hown at baseline (shaded columns), after bypass (black columns), and at 
recovery (hatched columns) for three age groups: less than 1 month, 1 to 12 months, and older than 12 
months. Column graph shows variable baseline levels in older age groups.Asterisks show significant p values 
versus baseline as follows: younger than 1 month: postbypass, p = 0.006; 1 to 12 months: postbypass, p < 
0.001 and recovery, p < 0.01; older than 1 year: postbypass, p' < 0.001 and recovery, p < 0.001. Amount 
of changes was not significantly different for three groups. 
tive rate of oxygen consumption i  the cell for all o f  
the subjects before bypass was 0.59% _+ 0.03% of 
oxygen per minute. The postbypass rate. or "slope" 
for the entire group (n = 30) was 3.87% _+ 0.48% of 
oxygen per minute. On the basis of this observation, 
we then attempted to quench the spontaneous oxi- 
dation at the time of sample draw in the operating 
room by adding a variety of agents to the sample. 
These included ethylene diaminetetraacetic a id, 
deferoxamine, catalase, superoxide dismutase, and 
n-mercaptopropionyl-glycine. To date, none of 
these interventions has produced normalization of 
the curve for TRAP oxygen consumption versus 
time (data not shown). 
Discuss ion  
This study demonstrates, with two separate meth- 
ods, depletion of the antioxidant capacity of plasma 
that has been exposed to an extracorporeal circuit. 
The observations add to the theory that cardiac 
bypass represents a total body inflammatory process. 
The oxygen radical generation suggested by this 
study and those of Roysten, ~ Fleming, 4 Davies, ~ 
Cavarocchi, ~ Del Nido, H and Teoh ~ and their 
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Fig. 4. Plasma antioxidant capacity (TRAP) after cardio- 
pulmonary bypass is totally depleted in 2t of 30 subjects. 
Prebypass tracings, obtained after induction of anesthesia, 
are identical to those generated from normal plasma. 
Postbypass plasma of these subjects hows rapid oxygen 
consumption rate without addition of ABAP reaction 
initiator. Oxygen consumption rate for postbypass plasma 
averages 3.87% -+ 0.48% oxygen per minute compared 
with 0.59% _+ 0.03% oxygen per minute at baseline before 
bypass. 
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associates i presumably a result of an interaction 
between the host and the bypass circuit rather than 
a reaction to hypoxia and reperfusion. Our data 
suggest hat this systemic reaction is largely com- 
pleted after the patient is weaned from bypass 
because antioxidant capacity changes little from 
after bypass in the operating room to recovery in the 
pediatric intensive care unit. By measurement of
antioxidant capacity of the sample rather than lipid 
peroxide levels or some other marker of oxygen 
radical activity, issues of the suitability of these tests 
for this patient population are avoided. 15' as 
Our study was designed to investigate the effect of 
cardiopulmonary b pass on plasma ntioxidant ca- 
pacity. After cardiopulmonary b pass, plasma anti- 
oxidant capacity was markedly diminished by both 
methods. Depletion of TRAP capacity correlated 
with young age and long bypass time. Antioxidant 
activity measured by beef brain MDA inhibition 
assay is also markedly diminished after cardiopul- 
monary bypass. Again, age correlates with antioxi- 
dant depletion. Length of cardiopulmonary b pass 
does not correlate well with extent of depletion of 
beef brain MDA inhibition. Although the TRAP 
test is designed to assess only secondary or chain- 
breaking antioxidant capacity and the beef MDA 
test measures total antioxidant capacity, the two 
tests show the same general trends. Beef MDA 
capacity is dearly more diminished for the subjects 
with complete depletion of secondary (chain break- 
ing) capacity as measured with the TRAP test. 
Antioxidant depletion after cardiopulmonary b pass 
correlates with well-known clinical indicators of 
increased morbidity in operations for congenital 
cardiac disease, namely age and length of bypass. 19 
Our finding that p0stbypass plasma-induced oxi- 
dation of linoleic acid, without addition of the 
radical generator ABAP, is of great interest. The 
reason for this spontaneous oxidation of postbypass 
plasma is unknown. Several mechanisms are possi- 
ble and include preservation of a relatively stable 
(possibly carbon centered) radical such as ascorbate 
in the plasma or formation through red blood cell 
hemolysis of a powerful Fenton reagent able to 
greatly accelerate the rate of spontaneous radical 
production in vitro. 2~ 21 A large body of evidence 
suggests' that oxygen radicals mediate the patho- 
physiologic changes observed after ischemia and 
reperfusion, zz-24 Recent studies have suggested that 
the immature heart may be more susceptible to 
reperfusion i jury and support he idea that neither 
rieutrophils nor endothelial cells are absolute pre- 
requisites for reoxygenation-induced myocardial in- 
jury.2S, 26 Compatible with a reoxygenation/reperfu- 
sion ,injury, Corno and associates 27 have shown 
markedly improved preservation ofventricular func- 
tion after 12 hours of ischemic arrest in piglets when 
the oxygen radical scavenging agents superoxide 
dismutase and catalase are administered atthe time 
of arrest. 27 Del Nido and co-workers 11 demon- 
strated the presence of linoleate- and arachidonate- 
derived" conjugated ienes in myocardial samples 
from patients undergoing elective repair of tetralogy 
of Fallot as the patients were placed on cardiopul- 
monary bypass, suggesting that free radical genera- 
tion and injury to myocardium could occur with 
initiation of bypass and not necessarily after cardio- 
plegia or circulatory arrest. In a later study, Teoh 
and colleagues 12reported that patients with tetral- 
ogy of Fallot had decreased levels of myocardial 
antioxidant enzymes and suggested that this predis- 
posed the cyanotic patients to reperfusion injury 
after cardiac operation. It is possible that these 
patients are at risk for greater oxidative damage 
related to the bypass circuit, although we did not 
have a large enough population of children with 
cyanosis to investigate this. 
Elucidation of the time frame and necessary 
component s hat produce the humoral cascade, neu- 
trophil activation, and oxygen radical generation will 
require further study but may determine future 
improvements o the cardiopulmonary b pass pro- 
cess. Efficacy of oxygen radical scavengers can be 
tested without exposing patients or animals to anti- 
oxidant agents with use of the assay systems de- 
scribed in this study. Further investigation to deter- 
mine the etiologic process of the accelerated 
postbypass oxygen consumption in the TRAP cell 
will be of interest because this may provide a clue to 
an optimal antioxidant regimen for cardiopulmo- 
nary bypass. 
We gratefully acknowledge the assistance of Gerrald 
Hobbs, PhD, who provided statistical consultation, and 
Cath3~ Guthrie, who prepared the manuscript. 
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